Home Daily Stock Opinions and Ratings Veru (VERU-Q)

Trending stocks today

Harvest Equal Weight Global Utilities Income ETF BYD Company Adobe Systems Ensign Resource Service Group Royalty Pharma plc Comcast Corp Onity Group. Inc. Allstate CVS Health Corp Nestle Savaria Corp Jamieson Wellness Stella-Jones Inc. Tesla Inc CVS Health Corp Advanced Micro Devices Broadcom Mastercard Inc. Superior Plus Corp

Veru (VERU-Q)

NEW AI Investor Insights
18 watching

NASDAQ:VERU

0.75
0.02 (2.10%) 1d
Dec 12, 2024, 8:36 pm
0
DON'T BUY

Veru(VERU-Q)

17/10/2022
Veru
64% of this company's share floated is shorted, so the market is betting against it.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$11.470
Unknown
UnlockRating
BUY

Veru(VERU-Q)

10/01/2022
Veru
Their breast cancer treatment just got fast-tracked by the FDA today. And yet, shares fell $5. This makes no sense. This should have risen.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$5.340
Unknown
UnlockRating
BUY

Veru(VERU-Q)

10/11/2021
Veru
Their prostate cancer drug is real. For $8/share, you're in good shape.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$8.370
Unknown
UnlockRating
BUY

Veru(VERU-Q)

26/04/2021
Veru
It's come down a lot--too much, but boasts some fine drugs. A crazy trading stock, but he believes in it.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$9.430
Unknown
UnlockRating
BUY

Veru(VERU-Q)

08/02/2021
Veru
It soared 28% today off great Covid drug data. They've been developing treatments for breast and prostate cancers. A few months ago, the stock tripled on stage 2 clinical trial data for their breast cancer therapy. Earlier this year, they started studying one of their cancer drugs to treat acute respiratory distress caused by severe Covid. This drug showed an 82% in deaths. Phase 3 results will likely come in Q4.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$13.920
Unknown
UnlockRating
BUY

Veru(VERU-Q)

14/12/2020
Veru
It was the biggest gainer in biotech today, this little-known name which soared 52.56% today. This drugmaker focuses on oncology and urology. It's tripled in the past week. They just produced promising phase 2 clinical trial data for their drugs treating breast cancer, and more positive data for prostate cancer. He doesn't chase stocks after a big run, but positive trial data spells a promising stock.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$9.695
Unknown
UnlockRating
Showing 1 to 6 of 6 entries
  • «
  • ‹
  • 1
  • ›
  • »

Veru(VERU-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Veru is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Veru(VERU-Q) Frequently Asked Questions

What is Veru stock symbol?

Veru is a American stock, trading under the symbol VERU-Q on the NASDAQ (VERU). It is usually referred to as NASDAQ:VERU or VERU-Q

Is Veru a buy or a sell?

In the last year, there was no coverage of Veru published on Stockchase.

Is Veru a good investment or a top pick?

Veru was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Veru.

Why is Veru stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Veru worth watching?

0 stock analysts on Stockchase covered Veru In the last year. It is a trending stock that is worth watching.

What is Veru stock price?

On 2024-12-12, Veru (VERU-Q) stock closed at a price of $0.75.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

V-NVisa Inc.
Visa Inc.
$314.38
0.59 (0.19%)
AQN-TAlgonquin Power & Utilities Corp
Algonquin Power & Utilities Corp
$6.42
-0.02 (-0.31%)
BEP.UN-TBrookfield Renewable Energy
Brookfield Renewable Energy
$33.88
-0.31 (-0.92%)
H-THydro One
Hydro One
$44.32
-0.19 (-0.43%)
MFC-TManulife Financial
Manulife Financial
$44.00
-0.60 (-1.38%)
Advertising

Today's Top Picks

SPB-TSuperior Plus Corp
Superior Plus Corp
$6.49
-0.25 (-4.01%)
MA-NMastercard Inc.
Mastercard Inc.
$532.53
-1.92 (-0.36%)
AVGO-QBroadcom
Broadcom
$180.94
-2.26 (-1.26%)
AMD-QAdvanced Micro Devices
Advanced Micro Devices
$130.62
0.47 (0.36%)
CVS-NCVS Health Corp
CVS Health Corp
$49.58
-2.18 (-4.60%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

DG-NDollar General Corp.
Dollar General Corp.
$78.45
-1.37 (-1.78%)
VRT-NVertiv Holdings
Vertiv Holdings
$125.07
-0.77 (-0.62%)
CEG-QConstellation Energy
Constellation Energy
$238.99
2.39 (0.99%)
FLO-NFlowers Foods
Flowers Foods
$21.23
-0.07 (-0.31%)
AQN-TAlgonquin Power & Utilities Corp
Algonquin Power & Utilities Corp
$6.42
-0.02 (-0.31%)

Most Recent Experts

Pyle

Andrew Pyle

The Pyle Group, Scotia Wealth Mgt.

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Takacsy

Stephen Takacsy, B. Eng, MBA

Lester Asset Management

Stockchase

Stockchase Insights

5i Research

Cramer

Jim Cramer - Mad Money

CNBC

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.